JJ
SENS icon

Johnson & Johnson’s Senseonics Holdings Inc SENS Stock Holding History

Johnson & Johnson’s Portfolio SENS Stock Details SENS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,731
Closed -$23.8K – 20
2025
Q3 		$23.8K Hold
2,731
– – ﹤0.01% 20
2025
Q2 		$27K Hold
2,731
– – 0.01% 20
2025
Q1 		$35.8K Hold
2,731
– – 0.01% 20
2024
Q4 		$28.6K Hold
2,731
– – 0.01% 20
2024
Q3 		$19.1K Hold
2,731
– – ﹤0.01% 20
2024
Q2 		$21.8K Hold
2,731
– – 0.01% 20
2024
Q1 		$29K Hold
2,731
– – ﹤0.01% 22
2023
Q4 		$31.1K Hold
2,731
– – ﹤0.01% 21
2023
Q3 		$33K Hold
2,731
– – 0.01% 22
2023
Q2 		$41.7K Hold
2,731
– – 0.01% 20
2023
Q1 		$38.8K Hold
2,731
– – 0.01% 21
2022
Q4 		$56K Hold
2,731
– – 0.02% 20
2022
Q3 		$72K Hold
2,731
– – 0.02% 20
2022
Q2 		$56K Hold
2,731
– – 0.01% 21
2022
Q1 		$108K Hold
2,731
– – 0.02% 20
2021
Q4 		$146K Hold
2,731
– – 0.02% 22
2021
Q3 		$185K Buy
+2,731
New +$185K 0.02% 24

Other funds holding SENS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Johnson & Johnson's SENS Position: Q4 2025 in Review

Johnson & Johnson sold out of Senseonics Holdings Inc (SENS) in Q4 2025, closing a stake of 2,731 shares — an estimated $23.8K sold.

Johnson & Johnson first reported a position in SENS in Q3 2021 and held it in 17 quarters. The position peaked at $185K in Q3 2021. 88 funds tracked by Wall St. Rank hold SENS as of Q4 2025.

  • Johnson & Johnson reported no remaining Senseonics Holdings Inc position as of Q4 2025 after selling out during the quarter.
  • Johnson & Johnson sold 2,731 Senseonics Holdings Inc shares in Q4 2025, an estimated $23.8K.
  • Johnson & Johnson first reported a position in Senseonics Holdings Inc in Q3 2021 and held it in 17 quarters.
  • Johnson & Johnson's Senseonics Holdings Inc position peaked at $185K in Q3 2021.
  • 88 funds tracked by Wall St. Rank held Senseonics Holdings Inc as of Q4 2025.

Based on Johnson & Johnson's 13F filing for Q4 2025, filed 13 Feb 2026.